Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field. Volckmar AL, Christopoulos P, Kirchner M, Allgauer M, et al. Lung Cancer 2021;154:131-141.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Volckmar AL, Christopoulos P, Kirchner M, Allgauer M, et al. Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field. Lung Cancer 2021;154:131-141.
PMID: 33667718